ClinicalTrials.gg
CompletedNCT07831564Updated Sep 21, 2026

Professional Oral Care and Staff Education in Critically Ill Patients

An interventional study of Professional Oral Care and Standard Oral Care in Critically Ill, Oral Health Care and Critical Illness, sponsored by Semmelweis University. Completed at 2 sites in Hungary. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Primary conditionCritical Illness(the registry's first term)UnverifiedIs this wrong?Critical Illness is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Semmelweis University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 years 2 months after the study started (first participant enrolled Jun 2023, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
161
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluated oral health in critically ill patients admitted to two intensive care units in Budapest, Hungary, and examined whether professional oral care and education of intensive care staff could improve oral hygiene. A total of 161 adult patients were included. Dentate patients in the first phase were randomly assigned to receive either professional oral care provided by dentists or standard oral care provided by ICU nursing staff. Total edentulous patients were included in a separate group. After a structured oral care education programme was provided to ICU staff, subsequently enrolled patients were included in a separate post-education group. Oral hygiene and gingival inflammation were assessed repeatedly during the ICU stay.

02

Conditions studied

  • Critically Ill
  • Oral Health Care
  • Critical Illness
  • Oral Care Performance

Browse trials for

Keywords

  • oral hygiene
  • oral care
  • critical illness
  • intensive care
  • orotracheal intubation
  • gingivitis
  • ventilator-associated pneumonia
  • staff education
03

In context

Critical Illness Unverified

1,780 studies on the registry are indexed under Critical Illness; 442 are open to participants now.

This study's enrollment of 161 is above the median of 90 across 926 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Semmelweis University is the lead sponsor of 140 studies on the registry; 56 are open to participants now.

Compared within Critical Illness, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (≥18 years of age) admitted to one of the participating intensive care units.
  • Expected ICU stay of at least 48 hours.
  • obtained from the patient or their legally authorized representative.

Exclusion criteria

Exclusion Criteria:

  • ICU stay shorter than 48 hours.
  • Refusal to participate or inability to obtain from the patient or their legally authorized representative.
  • Conditions associated with a high risk of bleeding that oral examination or oral care.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
161 participants (actual)

Study arms

  • Experimental
    Professional Oral Care

    Dentate patients randomly assigned during the first study phase to receive professional oral care provided by calibrated dentists three times weekly. Oral care was performed using a rotary-oscillatory electric toothbrush and fluoride toothpaste, including cleaning of occlusal, buccal, and lingual tooth surfaces, followed by oral rinsing with sterile water.

    Behavioral: Professional Oral Care

  • Active comparator
    Standard oral care

    Dentate patients randomly assigned during the first study phase to receive standard oral care provided by ICU nursing staff according to local clinical practice. Standard care was performed twice daily.

    Behavioral: Standard Oral Care

  • Experimental
    Upskill

    Dentate patients enrolled after implementation of a structured staff education programme. The programme addressed oral hygiene, recommendations for prevention of ventilator-associated pneumonia, and the recommended oral care protocol, including toothbrushing with toothpaste and oral rinsing. Patients subsequently received standard oral care according to local ICU practice.

    Behavioral: Standard Oral Care · Behavioral: ICU Staff Oral Care Education

  • Other
    Total edentulous

    Total edentulous patients included in a separate non-randomized cohort. These patients received standard oral care according to local ICU practice.

    Behavioral: Standard Oral Care

Interventions

  • BehavioralProfessional Oral Care

    Professional oral care was provided by calibrated dentists three times weekly using a rotary-oscillatory electric toothbrush and fluoride toothpaste. Cleaning included the occlusal, buccal, and lingual tooth surfaces, followed by oral rinsing with sterile water.

  • BehavioralStandard Oral Care

    Standard oral care was provided by ICU nursing staff twice daily according to local clinical practice. At the Bajcsy-Zsilinszky Hospital ICU, care consisted of toothbrushing or oral swabbing with a non-chlorhexidine antiseptic solution. At the Trauma Center ICU, care consisted of chlorhexidine mouth rinsing combined with toothbrushing.

  • BehavioralICU Staff Oral Care Education

    A structured educational programme was provided to ICU physicians and nurses. The programme addressed oral hygiene, current recommendations for the prevention of ventilator-associated pneumonia, and the recommended oral care protocol, including toothbrushing with toothpaste and oral rinsing. Patients enrolled after completion of the education programme constituted the post-education (upskill) group.

06

What researchers measure

Primary outcomes

  1. Change in Simplified Oral Hygiene Index (OHI-S) over time

    Oral hygiene was assessed using the Simplified Oral Hygiene Index (OHI-S), which ranges from 0 to 6, with higher scores indicating poorer oral hygiene. OHI-S scores were compared between study groups and across repeated examinations during the ICU stay.

    Time frame: Baseline and three times weekly during the ICU stay, through ICU discharge, an average of 30 days.

Secondary outcomes

  1. Change in gingivitis prevalence over time

    Gingival inflammation was assessed clinically at each oral examination. Gingivitis prevalence was compared between study groups and across repeated examinations during the ICU stay.

    Time frame: Baseline and three times weekly during the ICU stay, through ICU discharge, an average of 30 days.

  2. Incidence of ventilator-associated pneumonia (VAP)

    Occurrence of VAP during the ICU stay, recorded as a dichotomous outcome (yes/no) at the end of the ICU stay. VAP was defined according to the diagnostic criteria used in the participating ICUs, including onset at least 48 hours after initiation of mechanical ventilation.

    Time frame: Through ICU discharge, an average of 30 days.

  3. Duration of mechanical ventilation

    Duration of invasive mechanical ventilation, measured in days from initiation of mechanical ventilation until discontinuation or death, whichever occurred first.

    Time frame: From initiation of invasive mechanical ventilation until discontinuation or death, whichever occurred first, assessed up to 43 days.

  4. ICU length of stay

    Duration of the intensive care unit stay, measured in days from ICU admission until ICU discharge or death, whichever occurred first.

    Time frame: From ICU admission until ICU discharge or death, whichever occurred first, assessed up to 66 days.

  5. Hospital length of stay

    Duration of hospital stay, measured in days from hospital admission until hospital discharge or death, whichever occurred first.

    Time frame: From hospital admission until hospital discharge or death, whichever occurred first, assessed up to 103 days.

  6. All-cause mortality

    All-cause mortality during hospitalization, recorded as a dichotomous outcome (yes/no).

    Time frame: Up to 103 days after ICU admission.

07

Study locations

2 sites
  • Dr. Manninger Jenő National Trauma Center
    Budapest, 1081, Hungary
  • Bajcsy-Zsilinszky Hospital
    Budapest, 1106, Hungary
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2023 to primary completion in Mar 2025, 20 months.

Of 400 non-industry interventional studies with no phase under Critical Illness, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's 20 months is close to that.

Counting every sponsor, half of 404 studies reached it within 21 months; a quarter within 12 and three quarters within 40.

Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2026
First posted
Sep 21, 2026
StartActual
Jun 15, 2023
Primary completionActual
Mar 14, 2025
CompletionActual
Sep 9, 2025
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07831564
Responsible party
Sponsor
First posted
Sep 21, 2026
Start date
Jun 15, 2023
Primary completion
Mar 14, 2025
Completion
Sep 9, 2025
Last update
Sep 21, 2026

Study contacts

Szandra K Körmendi, PhD, DMD
principal investigator · Semmelweis University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion